The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(N-((2R,3S)-3-(((((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl)oxy)carbonyl)amino)-2-hydroxy-4-phenylbutyl)-N-isobutylsulfamoyl)benzoic acid ID: ALA5274743
Max Phase: Preclinical
Molecular Formula: C28H36N2O9S
Molecular Weight: 576.67
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(C(=O)O)cc1
Standard InChI: InChI=1S/C28H36N2O9S/c1-18(2)15-30(40(35,36)21-10-8-20(9-11-21)26(32)33)16-24(31)23(14-19-6-4-3-5-7-19)29-28(34)39-25-17-38-27-22(25)12-13-37-27/h3-11,18,22-25,27,31H,12-17H2,1-2H3,(H,29,34)(H,32,33)/t22-,23-,24+,25-,27+/m0/s1
Standard InChI Key: YSTCRWMBLFPEMC-GAYSTUHSSA-N
Molfile:
RDKit 2D
42 45 0 0 0 0 0 0 0 0999 V2000
-0.8162 5.5876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9880 4.7807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2737 4.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8869 3.8160 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
0.0615 3.6141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3511 2.8997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0610 2.1852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8860 2.1852 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3516 1.4708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0605 0.7562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8855 0.7562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2978 0.0413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8851 -0.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2973 -1.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1223 -1.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5351 -0.6735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1228 0.0413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3521 0.0419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1771 0.0419 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0601 -0.6726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3526 -1.3869 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1279 -1.6688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7597 -1.1383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6162 -0.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5351 -1.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0596 -2.1016 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.3530 -2.8159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0591 -3.5305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3535 -4.2446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1785 -4.2446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5912 -4.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1790 -5.6735 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4162 -4.9589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5907 -3.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1780 -2.8159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8821 3.7001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0538 4.5070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3395 4.9197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9528 5.4715 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
0.0042 5.6735 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7756 -2.5149 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7756 -1.6897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 1
3 5 1 0
5 6 1 6
6 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 1 1
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
10 18 1 0
18 19 1 1
18 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
21 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 1 0
31 32 1 0
31 33 2 0
30 34 2 0
34 35 1 0
35 27 2 0
5 36 1 0
37 36 1 0
38 3 1 0
38 37 1 0
38 39 1 1
1 40 1 0
40 38 1 0
26 41 2 0
26 42 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 576.67Molecular Weight (Monoisotopic): 576.2142AlogP: 2.49#Rotatable Bonds: 12Polar Surface Area: 151.70Molecular Species: ACIDHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.53CX Basic pKa: ┄CX LogP: 3.30CX LogD: -0.06Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.35Np Likeness Score: 0.10
References 1. Plescia J, Moitessier N.. (2020) Design and discovery of boronic acid drugs., 195 [PMID:32302879 ] [10.1016/j.ejmech.2020.112270 ] 2. Ghosh AK, Osswald HL, Prato G.. (2016) Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS., 59 (11): [PMID:26799988 ] [10.1021/acs.jmedchem.5b01697 ] 3. Ghosh AK, Shahabi D, Kipfmiller M, Ghosh AK, Johnson M, Wang YF, Agniswamy J, Amano M, Weber IT, Mitsuya H.. (2023) Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2' amide-derivatives: Synthesis, biological evaluation and structural studies., 83 [PMID:36738797 ] [10.1016/j.bmcl.2023.129168 ]